TCTMD1h
The ‘Smoker’s Paradox’ Takes A New Hit From Long-term Analysis
The DECADE data show a higher risk of death, MI, and stent thrombosis in people who smoked at the time of PCI with DES.
Ex-Bangladeshi captain Tamim Iqbal suffers heart attack, admitted to hospital
One of India's leading Digital News Agency offering Breaking News round the clock. Why not read our informative news portal ...
FDA approves new drug to treat heart conditions
The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of ...
Tamim Iqbal Health Update: Bangladesh Cricketer Recovering In ICU, What We Know So Far
Tamim Iqbal Health Live Tracker: Tamim Iqbal played 70 Tests and 243 ODIs, scoring 5,134 runs and 8,357 runs, respectively, ...
Crain's Chicago Business5h
Abbott gets green light for clinical trials of new heart treatment system
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Fierce Biotech6h
Abbott launches intravascular lithotripsy trial aimed at clearing coronary arteries
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
The Business Standard8h
From Malinga to Mashrafe to Hamza – everyone praying for Tamim
Following the news of Bangladesh’s top batsman falling ill, players from home and abroad have taken to social media to send ...
Just News BD8h
Tamim Iqbal regains consciousness, speaks with family
Former Bangladesh captain Tamim Iqbal who suffered a heart attack has regained consciousness after undergoing a stent ...
The American Journal of Managed Care9h
The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis
Experts discuss the clinical and economic burden of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis in the US, exploring their impact on health care systems, the importance of ...
Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...